Factors | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
RR | 95% CI | P | RR | 95% CI | P | |
Age (years) | 1.007 | 0.995–1.018 | 0.262 | |||
Sex (female/male) | 1.009 | 0.747–1.363 | 0.952 | |||
HBeAg-positive (−/+) | 3.031 | 2.209–4.158 | <0.001 | 1.834 | 1.246–2.698 | 0.002 |
Disease status (LC/CHB) | 1.577 | 1.172–2.121 | 0.003 | 1.028 | 0.748–1.411 | 0.867 |
MELD (<7/≥7) | 0.923 | 0.676–1.260 | 0.613 | |||
INR | 1.020 | 0.469–2.218 | 0.961 | |||
Serum ALT (IU/L) | 1.000 | 1.000–1.000 | 0.890 | |||
Serum total bilirubin (mg/dL) | 1.005 | 0.918–1.101 | 0.908 | |||
Serum albumin (g/dL) | 1.077 | 0.824–1.406 | 0.588 | |||
IVR-3 (+/−) | 4.851 | 2.902–8.109 | <0.001 | 3.403 | 1.977–5.859 | <0.001 |
Serum HBV DNA level (log10 IU/mL) | 0.638 | 0.569–0.715 | <0.001 | 0.817 | 0.696–0.958 | 0.013 |
Therapy regimens (TDF/ETV) | 1.162 | 0.868–1.555 | 0.313 |